These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30389329)

  • 1. The Role of the FDA in Ensuring the Safety and Efficacy of Artificial Intelligence Software and Devices.
    Allen B
    J Am Coll Radiol; 2019 Feb; 16(2):208-210. PubMed ID: 30389329
    [No Abstract]   [Full Text] [Related]  

  • 2. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities in software-driven medical devices.
    Gordon WJ; Stern AD
    Nat Biomed Eng; 2019 Jul; 3(7):493-497. PubMed ID: 31278389
    [No Abstract]   [Full Text] [Related]  

  • 5. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advocates call for FDA to take tougher stance on postmarket safety studies.
    Kuehn BM
    JAMA; 2011 Oct; 306(15):1639-40, 1642. PubMed ID: 22009087
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019.
    Johnston JL; Dhruva SS; Ross JS; Rathi VK
    JAMA Intern Med; 2020 Dec; 180(12):1701-1703. PubMed ID: 33044513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technology in electrophysiology: FDA process and perspective.
    Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B
    J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data.
    Fleurence RL; Forrest CB; Shuren J
    J Pediatr; 2019 Nov; 214():209-211. PubMed ID: 31378521
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical device regulation: an introduction for the practicing physician.
    Maisel WH
    Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
    Tau N; Shepshelovich D
    JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensuring safe and effective medical devices.
    Feigal DW; Gardner SN; McClellan M
    N Engl J Med; 2003 Jan; 348(3):191-2. PubMed ID: 12529457
    [No Abstract]   [Full Text] [Related]  

  • 14. Approval of high-risk medical devices in the US: implications for clinical cardiology.
    Rome BN; Kramer DB; Kesselheim AS
    Curr Cardiol Rep; 2014; 16(6):489. PubMed ID: 24760423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 17. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
    Nordberg M
    Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: medical devices.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal overprotection.
    Friedman JH
    Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.